Ernexa Therapeutics Inc. Other Expenses
Ernexa Therapeutics Inc. (ERNA) reported Other Expenses of $72.19 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherExpenses · last filed 2021-08-13
- Ernexa Therapeutics Inc. other expenses for the quarter ending 2021-06-30 was $72.19K, a 406.75% increase year-over-year.
- Ernexa Therapeutics Inc. other expenses for the quarter ending 2021-03-31 was $9.60M, a 205131.66% increase year-over-year.
- Ernexa Therapeutics Inc. other expenses for the quarter ending 2020-06-30 was $14.24K.
- Ernexa Therapeutics Inc. other expenses for the quarter ending 2020-03-31 was $4.68K.
- Ernexa Therapeutics Inc. other expenses for fiscal 2019 was $9.00K, a 93.43% decline from fiscal 2018.
- Ernexa Therapeutics Inc. other expenses for fiscal 2018 was $137.00K.
| Period end | Other Expenses 3 month | Other Expenses 6 month | Other Expenses 12 month |
|---|---|---|---|
| 2021-06-30 | $72.19K 10-Q · filed 2021-08-13 | $9.67M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $9.60M 10-Q · filed 2021-05-17 | ||
| 2020-06-30 | $14.24K 10-Q · filed 2021-08-13 | $18.92K 10-Q · filed 2021-08-13 | |
| 2020-03-31 | $4.68K 10-Q · filed 2021-05-17 | ||
| 2019-12-31 | $9.00K 10-K · filed 2020-03-19 | ||
| 2018-12-31 | $137.00K 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |